Alex Kramm

UBS’ Alex Kramm downgraded the rating for FactSet Research Systems Inc. (NYSE: FDS) from Neutral to Sell, while reducing the price target from $164 to $138. He mentioned that the market headwinds were “too strong to ignore.” While the company had a strong franchise, it was not...

Shares of Moody's Corporation (NYSE: MCO) have declined 11.43 percent over the past three months, while appreciating 2.43 percent year-to-date. Alex Kramm of UBS has upgraded the rating on the company from Neutral to Buy, while reiterating a price target of $116. Kramm believes that...

In a report published Tuesday, UBS analyst Alex Kramm downgraded the rating on Verisk Analytics, Inc. (NASDAQ: VRSK) from Neutral to Sell, while lowering the price target from $79 to $74. The stock appears overvalued at present, especially given the expectations of potential headwinds for the...

In a report published Friday, UBS Investment Research analyst Alex Kramm reiterated a Buy rating on MSCI (NYSE: MSCI), and raised the price target from $38.00 to $41.00. In the report, UBS Investment Research noted, “MSCI posted a solid beat and highlighted innovation, integration, and an...

In a report published Friday, UBS Investment Research analyst Alex Kramm reiterated a Buy rating on CME Group (NASDAQ: CME), but lowered the price target from $84.00 to $83.00. In the report, UBS Investment Research noted, “Despite solid 2Q results CME declined some 3% today. We believe...